article thumbnail

Moving Beyond Medicine To Treat Chronic Pain

MedCity News

I look at non-pharmacological approaches like digital therapeutics as having the potential to give someone like me living with chronic pain everything I need to make a healthy recovery: access to digital treatments and clinicians, to community, coaching, and navigation services.

article thumbnail

To Give Rare Disease Patients Hope, the FDA Must Re-Focus its Efforts

MedCity News

This would bring together specialized staff and resources from multiple review divisions to leverage their expertise about different bodily systems, trial designs, pharmacology, and other specialized fields. To bring cross-agency clinical leaders together, the FDA should establish a Center of Excellence for Rare Diseases.

FDA 297
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

With overdoses skyrocketing, Congress must consider non-opioid alternatives to pain management

MedCity News

Yet, they are too often overlooked by Congress and a healthcare system that tends to default to pharmacological treatments as the first step in pain reduction. Complementary and integrative healthcare providers, including chiropractic physicians, acupuncturists, and massage therapists, provide effective and safe treatments for pain.

article thumbnail

Extensive pharmacological review on Bauhinia racemosa Lam medicinal plant whose leaves are used to make Indian cigarettes (beedi’s)

Pharmatutor

Extensive pharmacological review on Bauhinia racemosa Lam medicinal plant whose leaves are used to make Indian cigarettes (beedi’s) admin Fri, 07/26/2024 - 10:52 Devansh Mehta* M.Pharmacy in Pharmacology, M.B.A. devanshm84@gmail.com

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

In this exclusive webinar, Dr. Ben Locwin will discuss the potential effects of this draft, along with the pharmacological and toxicological considerations for optimizing doses of prescription drugs.

article thumbnail

As Viatris seeks growth in eye care, its Ocuphire-partnered dilation drop Ryzumvi wins FDA nod

Fierce Pharma

The FDA on Wednesday approved Viatris and Ocuphire’s Ryzumvi, also known as phentolamine ophthalmic solution, to treat pharmacologically-induced mydriasis, or dilation of the pupils. Viatris just notched a win on its quest to reach $1 billion in eye care sales by 2028. | The partners plan to make Ryzumvi available in the U.S.

article thumbnail

Revolutionizing Primary Care: The Role of Pharmacogenomics and AI in Personalized Medicine

MedCity News

This rapidly growing field marries bioinformatics and pharmacology and represents a transformative new era of precision medicine and highly personalized treatments. The post Revolutionizing Primary Care: The Role of Pharmacogenomics and AI in Personalized Medicine appeared first on MedCity News.

Medicine 189